The Department of Veterans Affairs is conducting market research to identify sources of U.S.-produced pharmaceuticals, aiming to mitigate supply chain vulnerabilities. The focus is on products that fully qualify as U.S.-Produced under Executive Order 13944, though domestic manufacturing at any stage is valued. Interested companies must have a unique National Drug Code (NDC) and be able to provide a letter of commitment from the manufacturer if they are not the producer. The contract would ideally have a one-year base period plus four one-year options, with the ability to begin supplying within 60 days of award. Responses are requested by June 24, 2026, with no budget or performance location specified.